Choosing the wrong advisor for your healthcare transaction is one of the most expensive mistakes you can make before a deal even starts. You might leave money on the table, lose leverage with buyers, or spend months in a process that goes nowhere. A business broker and an investment banker are not interchangeable. Which one fits depends on deal size, transaction complexity, and what you actually need the advisor to do.
This article helps you think through that decision clearly before you sign an engagement letter.
What a Healthcare Business Broker Actually Does
A healthcare business broker connects sellers with buyers, primarily in smaller transactions. Their core function is identifying potential buyers, facilitating introductions, and moving a deal to close. For a single-location medical practice, a small dental group, or a home health agency with modest revenue, a capable broker can be exactly what the transaction requires.
Brokers typically work on deals ranging from a few hundred thousand dollars up to around $5 million in transaction value, though some operate in the lower mid-market. The key variable is whether the broker has genuine healthcare-specific experience. A general business broker who occasionally sells medical practices is not the same as one who understands payor mix, regulatory exposure, licensure transfer, and the clinical staff dynamics that shape buyer confidence. Fee structures are usually success-based commissions, often between 8 and 12 percent of the transaction value, which keeps their incentives aligned with closing.
What an Investment Banker Brings to a Healthcare Transaction
An investment banker takes on a broader scope of work. Rather than connecting a seller with a single buyer, they manage the entire sale process, from preparing marketing materials and running competitive outreach to structuring offers and negotiating terms. In healthcare M&A, this typically means preparing a detailed confidential information memorandum, running a structured auction, and engaging institutional buyers, strategic acquirers, and private equity groups simultaneously.
Investment bankers also lead valuation work, help you understand how buyers will model your business, and provide negotiation support from the letter of intent through due diligence. For deals with $2 million or more in EBITDA, or for multi-location platforms, that structured process can generate real competition among sophisticated buyers and produce a meaningfully better outcome. Fee models typically include a retainer plus a success fee, often structured on a Lehman or modified Lehman scale.
Where the Two Paths Diverge: Key Differences That Matter
The clearest dividing line is deal size. Brokers operate effectively below the threshold where institutional buyers become relevant. Investment bankers are built for transactions where competitive tension among multiple sophisticated buyers drives value. If your buyer universe is local physicians or small regional operators, a broker may be sufficient. If private equity groups or large health systems are logical acquirers, you need an investment banker running a real process.
The depth of service also differs. A broker facilitates. An investment banker manages. One connects parties and helps them reach an agreement. The other positions your business, controls information flow, and engineers competition. Fee models reflect this gap. A broker’s commission may feel steep on a smaller deal. Still, an investment banker’s retainer and success fee on a larger transaction are tied to a far more intensive process with significantly more at stake.
How Deal Size Should Drive Your Decision
As a general guide, practices or businesses with under $1 million in EBITDA are typically better served by a broker. Those with $2 million or more in EBITDA warrant an investment banking engagement. The range in between requires honest judgment about your goals and the realistic pool of buyers available to you.
A broker may underserve a mid-market healthcare seller by limiting buyer exposure to a narrow group without the resources or appetite to pay a premium. An investment banker may be unnecessary for a single-location practice where the likely buyer is a local physician group or small DSO. Misalignment runs in both directions. Over-advising creates cost without return. Under-advising leaves value on the table. If you sit in the gray zone, get a valuation opinion first, then decide which type of advisor fits the deal you are actually likely to run.
Questions to Ask Before You Hire Anyone
Before you engage anyone, ask them to walk you through their health record. How many deals have they closed in your sector, and at what size? Who did they bring to the table as buyers, and how did they source them? How do they approach valuation and positioning your business to different buyer types?
Watch for red flags. Vague timelines without clear milestones, upfront fees disconnected from specific deliverables, and thin healthcare experience dressed up in general M&A credentials are all signals worth taking seriously. The advisor you choose will shape how buyers perceive your business and how much leverage you have going into negotiations. That is not a role to fill based on a referral alone.
What the Right Advisor Actually Looks Like for Your Situation
The right advisor matches your goals, not your deal size alone. If speed matters most, you want someone with an active buyer network and a track record of efficient closes. If maximizing price is the priority, you need someone who can generate real competition. If deal structure, earnouts, or equity rollover are in play, you need an advisor who knows how to negotiate those terms and protect your position through due diligence.
Firm size and brand name matter less than operator-level experience in healthcare M&A. An advisor who has been on the operator side of a transaction understands what buyers scrutinize and where deals break down, bringing a different quality of guidance than one who has only managed the process from the outside. That perspective is what helps you avoid the surprises that erode value late in a deal.
FAQs
When should I hire a business broker versus an investment banker?
Businesses with under $1 million in EBITDA are typically better served by a broker, while those with $2 million or more in EBITDA warrant an investment banker who can run a competitive process with institutional buyers.
How do fee structures differ between brokers and investment bankers?
Brokers usually charge a success-based commission of 8 to 12 percent of transaction value, while investment bankers combine a retainer with a success fee, often on a Lehman or modified Lehman scale.
Why does healthcare-specific experience matter when choosing an M&A advisor?
A general advisor may miss critical factors like payer mix, licensure transfer, and regulatory exposure, all of which directly affect buyer confidence and the leverage you carry into negotiations.
Choose the Advisor Before the Market Chooses for You
The right M&A advisor can improve the quality of your buyer pool, strengthen your process, and shape the outcome you ultimately defend at the table. Before you engage a broker or investment banker, make sure the advisor understands healthcare deal dynamics, buyer behavior, valuation pressure, and where transactions lose momentum. Get perspective from someone who has worked across healthcare operations, investment banking, and M&A by contacting us at Inflection 360.
